Literature DB >> 16467531

Loss of leukemia inhibitory factor receptor beta or cardiotrophin-1 causes similar deficits in preganglionic sympathetic neurons and adrenal medulla.

Stephan Oberle1, Andreas Schober, Verena Meyer, Bettina Holtmann, Christopher Henderson, Michael Sendtner, Klaus Unsicker.   

Abstract

Leukemia inhibitory factor (LIF) receptor beta (LIFRbeta) is a receptor for a variety of neurotrophic cytokines, including LIF, ciliary neurotrophic factor (CNTF), and cardiotrophin-1 (CT-1). These cytokines play an essential role for the survival and maintenance of developing and postnatal somatic motoneurons. CNTF may also serve the maintenance of autonomic, preganglionic sympathetic neurons (PSNs) in the spinal cord, as suggested by its capacity to prevent their death after destruction of one of their major targets, the adrenal medulla. Although somatic motoneurons and PSNs share a common embryonic origin, they are distinct in several respects, including responses to lesions. We have studied PSNs in mice with targeted deletions of the LIFRbeta or CT-1 genes, respectively. We show that LIF, CNTF, and CT-1 are synthesized in embryonic adrenal gland and spinal cord and that PSNs express LIFRbeta. In embryonic day 18.5 LIFRbeta (-/-) and CT-1 (-/-) mice, PSNs were reduced by approximately 20%. PSNs projecting to the adrenal medulla were more severely affected (-55%). Although LIFRbeta (-/-) mice revealed normal numbers of adrenal chromaffin cells and axons terminating on chromaffin cells, levels of adrenaline and numbers of adrenaline-synthesizing cells were significantly reduced. We conclude that activation of LIFRbeta is required for normal development of PSNs and one of their prominent targets, the adrenal medulla. Thus, both somatic motoneurons and PSNs in the spinal cord depend on LIFRbeta signaling for their development and maintenance, although PSNs seem to be overall less affected than somatic motoneurons by LIFRbeta deprivation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467531      PMCID: PMC6793615          DOI: 10.1523/JNEUROSCI.4127-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  The developmental expression of choline acetyltransferase (ChAT) and the neuropeptide VIP in chick sympathetic neurons: evidence for different regulatory events in cholinergic differentiation.

Authors:  U Ernsberger; H Patzke; H Rohrer
Journal:  Mech Dev       Date:  1997-11       Impact factor: 1.882

Review 2.  Oncostatin M in the development of the nervous system.

Authors:  Yoshihiro Morikawa
Journal:  Anat Sci Int       Date:  2005-03       Impact factor: 1.741

3.  Cell density and exogenous CNTF affect CNTF mRNA levels in glial cell cultures.

Authors:  V Meyer; K Unsicker
Journal:  Neuroreport       Date:  1994-10-03       Impact factor: 1.837

4.  Glial cell line-derived neurotrophic factor rescues target-deprived sympathetic spinal cord neurons but requires transforming growth factor-beta as cofactor in vivo.

Authors:  A Schober; R Hertel; U Arumäe; L Farkas; J Jaszai; K Krieglstein; M Saarma; K Unsicker
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

5.  Cell death of motoneurons in the chick embryo spinal cord. VI. Reduction of naturally occurring cell death in the thoracolumbar column of Terni by nerve growth factor.

Authors:  R W Oppenheim; J L Maderdrut; D J Wells
Journal:  J Comp Neurol       Date:  1982-09-10       Impact factor: 3.215

6.  Maintenance of Intermediolateral Spinal Cord Neurons by Fibroblast Growth Factor Administered to the Medullectomized Rat Adrenal Gland: Dependence on Intact Adrenal Innervation and Cellular Organization of Implants.

Authors:  Dieter Blottner; Klaus Unsicker
Journal:  Eur J Neurosci       Date:  1990       Impact factor: 3.386

7.  Nitric oxide synthetase (NOS)-containing sympathoadrenal cholinergic neurons of the rat IML-cell column: evidence from histochemistry, immunohistochemistry, and retrograde labeling.

Authors:  D Blottner; H G Baumgarten
Journal:  J Comp Neurol       Date:  1992-02-01       Impact factor: 3.215

8.  Leukaemia inhibitory factor rescues motoneurones from axotomy-induced cell death.

Authors:  S S Cheema; L J Richards; M Murphy; P F Bartlett
Journal:  Neuroreport       Date:  1994-04-14       Impact factor: 1.837

9.  Cardiotrophin-like cytokine/cytokine-like factor 1 is an essential trophic factor for lumbar and facial motoneurons in vivo.

Authors:  Nancy G Forger; David Prevette; Odile deLapeyrière; Béatrice de Bovis; Siwei Wang; Perry Bartlett; Ronald W Oppenheim
Journal:  J Neurosci       Date:  2003-10-01       Impact factor: 6.167

10.  Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130.

Authors:  D P Gearing; C J Thut; T VandeBos; S D Gimpel; P B Delaney; J King; V Price; D Cosman; M P Beckmann
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  10 in total

1.  Protective effects of leukemia inhibitory factor against oxidative stress during high glucose-induced apoptosis in podocytes.

Authors:  Jing Xu; Zhigui Li; Pengjuan Xu; Zhuo Yang
Journal:  Cell Stress Chaperones       Date:  2012-01-22       Impact factor: 3.667

2.  Mechanism of shortened bones in mucopolysaccharidosis VII.

Authors:  Jason A Metcalf; Yanming Zhang; Matthew J Hilton; Fanxin Long; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2009-03-25       Impact factor: 4.797

3.  Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.

Authors:  Daniel J Rowan; Shunji Tomatsu; Jeffrey H Grubb; Adriana M Montaño; William S Sly
Journal:  J Inherit Metab Dis       Date:  2012-09-13       Impact factor: 4.982

4.  Transforming growth factor-{beta} coordinately induces suppressor of cytokine signaling 3 and leukemia inhibitory factor to suppress osteoclast apoptosis.

Authors:  Ming Ruan; Larry Pederson; Elizabeth W Bradley; Ana-Maria Bamberger; Merry Jo Oursler
Journal:  Endocrinology       Date:  2010-02-24       Impact factor: 4.736

5.  Age-dependent regulation of chromaffin cell proliferation by growth factors, dehydroepiandrosterone (DHEA), and DHEA sulfate.

Authors:  Flavie Sicard; Monika Ehrhart-Bornstein; Denis Corbeil; Simone Sperber; Alexander W Krug; Christian G Ziegler; Valeria Rettori; Samuel M McCann; Stefan R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

6.  Neuropathies of Stüve-Wiedemann Syndrome due to mutations in leukemia inhibitory factor receptor (LIFR) gene.

Authors:  Alexandra E Oxford; Cheryl L Jorcyk; Julia Thom Oxford
Journal:  J Neurol Neuromedicine       Date:  2016

7.  The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response.

Authors:  Kurt Gritman; Donna M Van Winkle; Christina U Lorentz; Diane Pennica; Beth A Habecker
Journal:  Cytokine       Date:  2006-12-05       Impact factor: 3.861

8.  Progressive postnatal motoneuron loss in mice lacking GDF-15.

Authors:  Jens Strelau; Adam Strzelczyk; Patricia Rusu; Gerald Bendner; Stefan Wiese; Francesca Diella; Amy L Altick; Christopher S von Bartheld; Rüdiger Klein; Michael Sendtner; Klaus Unsicker
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

Review 9.  Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology.

Authors:  Dawn Mikelonis; Cheryl L Jorcyk; Ken Tawara; Julia Thom Oxford
Journal:  Orphanet J Rare Dis       Date:  2014-03-12       Impact factor: 4.123

10.  ApoER2 and VLDLr are required for mediating reelin signalling pathway for normal migration and positioning of mesencephalic dopaminergic neurons.

Authors:  Ahmed Sharaf; Hans H Bock; Björn Spittau; Elisabeth Bouché; Kerstin Krieglstein
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.